Publication | Closed Access
Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection
55
Citations
13
References
1998
Year
COL-1492 showed minimal toxicity when applied once daily. A Phase III trial to assess the product's effectiveness in HIV prevention is currently ongoing.
| Year | Citations | |
|---|---|---|
Page 1
Page 1